Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 1
1981 3
1982 4
1984 1
1985 1
1986 2
1987 3
1988 3
1989 2
1990 3
1992 3
1993 2
1994 2
1995 2
1996 4
1997 2
1998 2
1999 8
2000 5
2001 1
2002 4
2003 1
2004 3
2005 2
2006 2
2007 4
2008 3
2009 2
2010 5
2011 1
2012 4
2013 5
2014 3
2015 6
2016 2
2017 7
2018 3
2019 6
2020 9
2021 13
2022 8
2023 16
2024 9
2025 15
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Eubacterium limosum as a biocatalyst for sustainable methanol bioconversion.
Bae J, Jung H, Cho BK. Bae J, et al. Curr Opin Biotechnol. 2025 Dec;96:103354. doi: 10.1016/j.copbio.2025.103354. Epub 2025 Sep 10. Curr Opin Biotechnol. 2025. PMID: 40934833 Free article. Review.
Eubacterium limosum is an acetogenic bacterium capable of utilizing one-carbon substrates - CO(2), CO, formate, and methanol - while producing valuable reduced compounds, including butyrate and hexanoate. ...
Eubacterium limosum is an acetogenic bacterium capable of utilizing one-carbon substrates - CO(2), CO, formate, and methanol - …
Traditional Medicine Pien Tze Huang Suppresses Colorectal Tumorigenesis Through Restoring Gut Microbiota and Metabolites.
Gou H, Su H, Liu D, Wong CC, Shang H, Fang Y, Zeng X, Chen H, Li Y, Huang Z, Fan M, Wei C, Wang X, Zhang X, Li X, Yu J. Gou H, et al. Gastroenterology. 2023 Dec;165(6):1404-1419. doi: 10.1053/j.gastro.2023.08.052. Epub 2023 Sep 12. Gastroenterology. 2023. PMID: 37704113 Free article.
PZH treatment altered the gut microbiota profile, with an increased abundance of probiotics Pseudobutyrivibrio xylanivorans and Eubacterium limosum, while pathogenic bacteria Aeromonas veronii, Campylobacter jejuni, Collinsella aerofaciens, and Peptoniphilus harei w …
PZH treatment altered the gut microbiota profile, with an increased abundance of probiotics Pseudobutyrivibrio xylanivorans and Eubacteri …
Eubacterium limosum modulates tumor microenvironments and produces antitumor metabolites active against colorectal cancer.
Lu Y, Lan R, Fan Q, Tang H, Hu D, Zhang S, Lin X, Wang R, Zhao R, Sun H, Liu L, Xu J. Lu Y, et al. ISME J. 2025 Jan 2;19(1):wraf130. doi: 10.1093/ismejo/wraf130. ISME J. 2025. PMID: 40568973 Free PMC article.
Gut microbiota play a key role in ameliorating colorectal cancer (CRC). Eubacterium limosum is a potential probiotic with anti-CRC functions. However, the mechanistic basis of its anti-CRC effect remains largely unknown. ...
Gut microbiota play a key role in ameliorating colorectal cancer (CRC). Eubacterium limosum is a potential probiotic with anti …
Eubacterium limosum modulates gut microbiota and produces anti-inflammatory metabolites to alleviate DSS-induced colitis.
Lu Y, Tang H, Fan Q, Lan R, Lin X, Zhang S, Liu L, Xu J. Lu Y, et al. Front Immunol. 2025 Dec 16;16:1728808. doi: 10.3389/fimmu.2025.1728808. eCollection 2025. Front Immunol. 2025. PMID: 41476955 Free PMC article.
The gut microbiota play a critical role in ameliorating IBD, and Eubacterium limosum has emerged as a potential probiotic with anti-inflammatory properties. ...
The gut microbiota play a critical role in ameliorating IBD, and Eubacterium limosum has emerged as a potential probiotic with …
Characterisation of acetogen formatotrophic potential using Eubacterium limosum.
Wood JC, Gonzalez-Garcia RA, Daygon D, Talbo G, Plan MR, Marcellin E, Virdis B. Wood JC, et al. Appl Microbiol Biotechnol. 2023 Jul;107(14):4507-4518. doi: 10.1007/s00253-023-12600-6. Epub 2023 Jun 5. Appl Microbiol Biotechnol. 2023. PMID: 37272938
Formate is a promising energy carrier that could be used to transport renewable electricity. Some acetogenic bacteria, such as Eubacterium limosum, have the native ability to utilise formate as a sole substrate for growth, which has sparked interest in the biotechno …
Formate is a promising energy carrier that could be used to transport renewable electricity. Some acetogenic bacteria, such as Eubacteriu …
Genome Engineering of Eubacterium limosum Using Expanded Genetic Tools and the CRISPR-Cas9 System.
Shin J, Kang S, Song Y, Jin S, Lee JS, Lee JK, Kim DR, Kim SC, Cho S, Cho BK. Shin J, et al. ACS Synth Biol. 2019 Sep 20;8(9):2059-2068. doi: 10.1021/acssynbio.9b00150. Epub 2019 Aug 12. ACS Synth Biol. 2019. PMID: 31373788
Eubacterium limosum is one of the important bacteria in C(1) feedstock utilization as well as in human gut microbiota. ...
Eubacterium limosum is one of the important bacteria in C(1) feedstock utilization as well as in human gut microbiota. ...
Genome Sequence of Eubacterium limosum B2 and Evolution for Growth on a Mineral Medium with Methanol and CO(2) as Sole Carbon Sources.
Pregnon G, Minton NP, Soucaille P. Pregnon G, et al. Microorganisms. 2022 Sep 5;10(9):1790. doi: 10.3390/microorganisms10091790. Microorganisms. 2022. PMID: 36144392 Free PMC article.
Eubacterium limosum is an acetogen that can produce butyrate along with acetate as the main fermentation end-product from methanol, a promising C1 feedstock. ...
Eubacterium limosum is an acetogen that can produce butyrate along with acetate as the main fermentation end-product from meth …
Gut symbiont-derived ursodeoxycholic acid promotes fatty acid oxidation to protect against renal ischemia-reperfusion injury.
Xie M, Zheng J, Yu Y, Yang Q, Zhou Z, Xue J, Wang B, Qiu Y, Zhu Z, Sun Q, Shi X, Shangguan W, Li L, Zou Z, Zhao J, Wu P. Xie M, et al. Cell Rep Med. 2025 Oct 21;6(10):102373. doi: 10.1016/j.xcrm.2025.102373. Epub 2025 Sep 26. Cell Rep Med. 2025. PMID: 41015035 Free PMC article.
Here, we find that renal IRI reduces ursodeoxycholic acid (UDCA), a metabolite of Eubacterium limosum (E. limosum), in mice cecal content and serum. Conversely, supplementation with either E. limosum or UDCA prevents these mice from IRI. ...
Here, we find that renal IRI reduces ursodeoxycholic acid (UDCA), a metabolite of Eubacterium limosum (E. limosum), in mice ce …
Deletion of biofilm synthesis in Eubacterium limosum ATCC 8486 improves handling and transformation efficiency.
Sanford PA, Miller KG, Hoyt KO, Woolston BM. Sanford PA, et al. FEMS Microbiol Lett. 2023 Jan 17;370:fnad030. doi: 10.1093/femsle/fnad030. FEMS Microbiol Lett. 2023. PMID: 37024282
Eubacterium limosum is an acetogenic bacterium of potential industrial relevance for its ability to efficiently metabolize a range of single carbon compounds. ...
Eubacterium limosum is an acetogenic bacterium of potential industrial relevance for its ability to efficiently metabolize a r …
Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity.
Kanauchi O, Fukuda M, Matsumoto Y, Ishii S, Ozawa T, Shimizu M, Mitsuyama K, Andoh A. Kanauchi O, et al. World J Gastroenterol. 2006 Feb 21;12(7):1071-7. doi: 10.3748/wjg.v12.i7.1071. World J Gastroenterol. 2006. PMID: 16534848 Free PMC article.
AIM: To examine the effect of Eubacterium limosum (E. limosum) on colonic epithelial cell line in vitro, and to evaluate the effect of E. limosum on experimental colitis. ...
AIM: To examine the effect of Eubacterium limosum (E. limosum) on colonic epithelial cell line in vitro, and to evaluate the e …
179 results